J, W., J, Z., B, Z., Y, Q., H, G., Y, Y., . . . Z, P. (2014). Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Dove Medical Press.
Style de citation Chicago (17e éd.)J, Wu, et al. Polyethylene Glycol–polylactic Acid Nanoparticles Modified with Cysteine–arginine–glutamic Acid–lysine–alanine Fibrin-homing Peptide for Glioblastoma Therapy by Enhanced Retention Effect. Dove Medical Press, 2014.
Style de citation MLA (8e éd.)J, Wu, et al. Polyethylene Glycol–polylactic Acid Nanoparticles Modified with Cysteine–arginine–glutamic Acid–lysine–alanine Fibrin-homing Peptide for Glioblastoma Therapy by Enhanced Retention Effect. Dove Medical Press, 2014.